NHS

News

woman suffering from uterine fibroid pain holding her abdomen

Theramex's uterine fibroid drug Yselty backed for NHS use

A daily oral therapy for uterine fibroids has been recommended for NHS by NICE, providing a new option for around 30,000 women in England and Wales.

News

NICE updates on controversial multiple myeloma decisions

NICE has defended a trio of decisions on new therapies for multiple myeloma, which saw two drugs approved for restricted use in England and Wales and a third turned down altogether.

News

After a no in sickle cell, NICE OKs Casgevy for thalassaemia

Vertex and CRISPR Therapeutics have won the backing of NICE for their gene-editing therapy Casgevy as a treatment for the blood disorder beta thalassaemia, a few months after turning it dow

News

NICE backs osteoporosis drug, but diagnosis is an obstacle

Around 14,000 women in England may soon be able to access a new treatment for osteoporosis after NICE backed routine NHS use of Theramex's Eladynos.

News

UK partnership aims to support NHS use of depression app

Otsuka has teamed up with one of the innovation arms of the NHS to explore how a digital therapeutic (DTx) for major depressive disorder (MDD) could be deployed within the health service.

News

NICE says Boehringer stroke drug 'could save millions'

In new guidance, NICE has cleared NHS use of Boehringer Ingelheim's clot-busting therapy Metalyse as a treatment for acute ischaemic stroke in adults.

Theramex's uterine fibroid drug Yselty backed for NHS use

NICE updates on controversial multiple myeloma decisions

After a no in sickle cell, NICE OKs Casgevy for thalassaemia

NICE backs osteoporosis drug, but diagnosis is an obstacle

UK partnership aims to support NHS use of depression app

NICE says Boehringer stroke drug 'could save millions'

Ambrosia's sweet $100m round, and other biofinancings

Using AI-driven synthetic personas to take your insights fur...

NHS

Editor's Picks